{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:06:27Z","timestamp":1788887187094,"version":"build-2803163510"},"reference-count":41,"publisher":"Informa UK Limited","issue":"8","funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["Code 2020YFC2008305"],"award-info":[{"award-number":["Code 2020YFC2008305"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.2217\/pgs-2023-0054","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T05:19:02Z","timestamp":1690521542000},"page":"459-474","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Carbamazepine Cutaneous Adverse Reactions and\n                    <i>HLA<\/i>\n                    Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4807-4096","authenticated-orcid":false,"given":"Qingli","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China"},{"name":"Beijing Key Laboratory of Evaluation of Rational Drug Use, Beijing, 100038, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3769-9233","authenticated-orcid":false,"given":"Hongyan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China"},{"name":"Beijing Key Laboratory of Evaluation of Rational Drug Use, Beijing, 100038, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China"},{"name":"Beijing Key Laboratory of Evaluation of Rational Drug Use, Beijing, 100038, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8575-3770","authenticated-orcid":false,"given":"Zhanmiao","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China"},{"name":"Institute for drug evaluation, Peking University Health Science Center, Beijing, 100191, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechun","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China"},{"name":"Beijing Key Laboratory of Evaluation of Rational Drug Use, Beijing, 100038, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"e_1_3_7_3_1","unstructured":"National Medical Products Administration . Pharmacovigilance alerts [DB\/OL] (2008). www.nmpa.gov.cn\/xxgk\/yjjsh\/ywjjkx\/20080128120001639.html."},{"key":"e_1_3_7_4_1","unstructured":"Medlive . Instructions for Carbamazepine [DB\/OL] (2022). https:\/\/drugs.medlive.cn\/drugref\/html\/12835.shtml"},{"key":"e_1_3_7_5_1","first-page":"51","article-title":"Screening the predisposing genes of carbamazepine adverse reaction and exploring its correlation with carbamazepine adverse reaction in epilepsy patients living in northeast region of Chin [D]","author":"He XJ","year":"2014","unstructured":"He XJ . Screening the predisposing genes of carbamazepine adverse reaction and exploring its correlation with carbamazepine adverse reaction in epilepsy patients living in northeast region of Chin [D]. Shen Yang China Med. Univ.51\u201368 (2014).","journal-title":"Shen Yang China Med. Univ."},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/428486a"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004008"},{"issue":"13","key":"e_1_3_7_8_1","first-page":"2136","article-title":"Correlation between the carbamazepine induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis and HLA-B gene in southern Han Chinese","volume":"28","author":"Qin B","year":"2012","unstructured":"Qin B , MinFL , ShiYW , LiaoWP. Correlation between the carbamazepine induced Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis and HLA-B gene in southern Han Chinese. J. Pract. Med.28(13), 2136\u20132139 (2012).","journal-title":"J. Pract. Med."},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-014-1247-7"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15792"},{"key":"e_1_3_7_11_1","first-page":"1","article-title":"A Han Chinese case of Stevens\u2013Johnson syndrome with positive HLA-A*3101 gene caused by carbamazepine [J\/OL]","volume":"2022","author":"Xu YY","year":"2023","unstructured":"Xu YY , SunZL , ZhagnXLet al. A Han Chinese case of Stevens\u2013Johnson syndrome with positive HLA-A*3101 gene caused by carbamazepine [J\/OL]. J. Peking Univ. Health Sci.2022, 1\u20134(2023)","journal-title":"J. Peking Univ. Health Sci."},{"issue":"11","key":"e_1_3_7_12_1","first-page":"917","article-title":"Carbamazepine-induced toxic epidermal necrolysis in a patient with HLA-A*31:01 allele","volume":"53","author":"Li LN","year":"2020","unstructured":"Li LN , ZhangJJ , ZhangSM. Carbamazepine-induced toxic epidermal necrolysis in a patient with HLA-A*31:01 allele. Chin. J. Dermatol.53(11), 917\u2013919 (2020).","journal-title":"Chin. J. Dermatol."},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2014.05.025"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02363-w"},{"issue":"2","key":"e_1_3_7_15_1","first-page":"108","article-title":"Association analysis between HLA-A\/B alleles and maculopapular exanthema induced by carbamazepine or oxcarbazepine","volume":"8","author":"He N","year":"2022","unstructured":"He N , SongW , LiuXRet al. Association analysis between HLA-A\/B alleles and maculopapular exanthema induced by carbamazepine or oxcarbazepine. J. Epilepsy8(2), 108\u2013115 (2022).","journal-title":"J. Epilepsy"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2013.10.003"},{"key":"e_1_3_7_17_1","unstructured":"The Ottawa Hospital Research Institute . The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [DB\/OL]. (2022). www.ohri.ca\/programs\/clinicalepidemiology\/oxford.asp."},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2011.02.003"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2010.08.007"},{"issue":"5","key":"e_1_3_7_20_1","first-page":"697","article-title":"Correlation analysis of HLA-B gene within MHC region with severe cutaneous reactions to antiepileptic drugs in Chinese Han population","volume":"22","author":"Zhang X","year":"2019","unstructured":"Zhang X , ChuHF , HuB , LuWS. Correlation analysis of HLA-B gene within MHC region with severe cutaneous reactions to antiepileptic drugs in Chinese Han population. Chin. J. Clin. Healthc.22(5), 697\u2013700 (2019).","journal-title":"Chin. J. Clin. Healthc."},{"key":"e_1_3_7_21_1","unstructured":"Zhou FY . HLA-B*1502 Gene Detection Guide the Safety and cost effectiveness of carbamazepine in The Treatment of Epilepsy analysis. University of South China Hu Bei China1\u201370 (2019)."},{"issue":"5","key":"e_1_3_7_22_1","first-page":"272","article-title":"Association between HLA-B*1502 allele and carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Hanzu people in Jiangxi province","volume":"43","author":"Liu OG","year":"2019","unstructured":"Liu OG , ZouYQ , LiCM , LiuZG. Association between HLA-B*1502 allele and carbamazepine-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Hanzu people in Jiangxi province. J. Clin. Dermatol.43(5), 272\u2013274 (2019).","journal-title":"J. Clin. Dermatol."},{"key":"e_1_3_7_23_1","first-page":"1","article-title":"Clinical data analysis and genetic and virological studies of severe cutaneous adverse reactions in Chinese Han population in South China","author":"Zheng XZ","year":"2018","unstructured":"Zheng XZ . Clinical data analysis and genetic and virological studies of severe cutaneous adverse reactions in Chinese Han population in South China. Guang Dong Shantou Univer.1\u201364 (2018).","journal-title":"Guang Dong Shantou Univer."},{"issue":"2","key":"e_1_3_7_24_1","first-page":"96","article-title":"Correlation between the allergic reaction of carbamazepine and HLA-B* 1502 gene in Uighur children with epilepsy in Xinjiang","volume":"34","author":"Aihetanmu Beilikezi","year":"2021","unstructured":"Aihetanmu Beilikezi , YimamuAbuduhailili. Correlation between the allergic reaction of carbamazepine and HLA-B* 1502 gene in Uighur children with epilepsy in Xinjiang. J. Clin. Neurol.34(2), 96\u201399 (2021).","journal-title":"J. Clin. Neurol."},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2013.40"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000287"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1009-4"},{"issue":"3","key":"e_1_3_7_28_1","first-page":"290","article-title":"Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients","volume":"29","author":"Then SM","year":"2011","unstructured":"Then SM , RaniZZ , RaymondAAet al. Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients. Asian Pac. J. Allergy Immunol.29(3), 290\u20133 (2011).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2012.00868.x"},{"issue":"7","key":"e_1_3_7_30_1","first-page":"16","article-title":"Association between HLA-B*15:02 allele and antiepileptic drug-induced severe cutaneous reactions in Hong Kong Chinese: a population-based study","volume":"20","author":"Kwan PK","year":"2014","unstructured":"Kwan PK , NgMH , LoSV. Association between HLA-B*15:02 allele and antiepileptic drug-induced severe cutaneous reactions in Hong Kong Chinese: a population-based study. Hong Kong Med. J.20 (7), 16\u20138 (2014).","journal-title":"Hong Kong Med. J."},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.671572"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1009-4"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000021"},{"key":"e_1_3_7_34_1","article-title":"Allele Frequency Search [DB\/OL]","author":"The Royal Liverpool and Broadgreen University Hospitals","year":"2023","unstructured":"The Royal Liverpool and Broadgreen University Hospitals . Allele Frequency Search [DB\/OL]. The Allele Frequency Net Database [HLA Allele Information] (2023). allelefrequencies.net.","journal-title":"The Allele Frequency Net Database [HLA Allele Information]"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111077"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2019.100037"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826aac73"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13291"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.115"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2011.01457.x"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165933"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13821"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.12.990"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2023-0054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:02:28Z","timestamp":1715983348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2023-0054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.2217\/pgs-2023-0054"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2023-0054","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}